The PI3K/Akt/mTOR signaling pathway was found to be potentially affected by m6A regulators in most cancers such as gastrointestinal cancer (Zhao Q. et al., 2020) and ovarian cancer (Bi et al., 2021), which was consistent with our results. The gene discussed is AKT1; the disease is ovarian carcinoma.